Allergy/Imm

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Webb TJ et al. - CD1d-Ig aAPC can expand NKT cells from cancer patients. Thus, CD1d-expressing aAPC will enhance the knowledge of NKT cell biology and could potentially be used as a novel tool in adoptive immunotherapeutic strategies.